Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moshe Finel

Showing results (41-50 of 122) with videos related to

Pageof 13
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 16, 2003
Glucuronidation of anabolic androgenic steroids by recombinant human UDP-glucuronosyltransferasesTiia Kuuranne, Mika Kurkela, Mario Thevis, et al.
Acta Pharmaceutica Sinica. B|April 12, 2019
Recent progress and challenges in screening and characterization of UGT1A1 inhibitorsXia Lv, Yangliu Xia, Moshe Finel, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|January 24, 2012
Highly variable pH effects on the interaction of diclofenac and indomethacin with human UDP-glucuronosyltransferasesHongbo Zhang, Anne Soikkeli, Ari Tolonen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 5, 2013
Regiospecificity and stereospecificity of human UDP-glucuronosyltransferases in the glucuronidation of estriol, 16-epiestriol, 17-epiestriol, and 13-epiestradiolNina Sneitz, Mikko Vahermo, Johanna Mosorin, et al.
Analytical Biochemistry|July 13, 2004
Microplate screening assay to identify inhibitors of human catechol-O-methyltransferaseMika Kurkela, Antti Siiskonen, Moshe Finel, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 4, 2005
Biosynthesis of dobutamine monoglucuronides and glucuronidation of dobutamine by recombinant human UDP-glucuronosyltransferasesAnna Alonen, Olli Aitio, Kati Hakala, et al.
Journal of Pharmaceutical Sciences|February 24, 2025
Efflux and uptake of androgen sulfates using transporter-overexpressing HEK293 cells and membrane vesiclesArttu Uoti, Erkka Järvinen, Noora Sjöstedt, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 10, 2006
Prominent but reverse stereoselectivity in propranolol glucuronidation by human UDP-glucuronosyltransferases 1A9 and 1A10Taina Sten, Saana Qvisen, Päivi Uutela, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|April 5, 2013
A high throughput assay for the glucuronidation of 7-hydroxy-4-trifluoromethylcoumarin by recombinant human UDP-glucuronosyltransferases and liver microsomesTuomas Rahikainen, Merja R Häkkinen, Moshe Finel, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 2, 2005
Kinetic characterization of the 1A subfamily of recombinant human UDP-glucuronosyltransferasesLeena Luukkanen, Jyrki Taskinen, Mika Kurkela, et al.
Pageof 13

Showing results (41-50 of 122) with videos related to

Sort By:
Pageof 13
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 16, 2003
Glucuronidation of anabolic androgenic steroids by recombinant human UDP-glucuronosyltransferasesTiia Kuuranne, Mika Kurkela, Mario Thevis, et al.
Acta Pharmaceutica Sinica. B|April 12, 2019
Recent progress and challenges in screening and characterization of UGT1A1 inhibitorsXia Lv, Yangliu Xia, Moshe Finel, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|January 24, 2012
Highly variable pH effects on the interaction of diclofenac and indomethacin with human UDP-glucuronosyltransferasesHongbo Zhang, Anne Soikkeli, Ari Tolonen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 5, 2013
Regiospecificity and stereospecificity of human UDP-glucuronosyltransferases in the glucuronidation of estriol, 16-epiestriol, 17-epiestriol, and 13-epiestradiolNina Sneitz, Mikko Vahermo, Johanna Mosorin, et al.
Analytical Biochemistry|July 13, 2004
Microplate screening assay to identify inhibitors of human catechol-O-methyltransferaseMika Kurkela, Antti Siiskonen, Moshe Finel, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 4, 2005
Biosynthesis of dobutamine monoglucuronides and glucuronidation of dobutamine by recombinant human UDP-glucuronosyltransferasesAnna Alonen, Olli Aitio, Kati Hakala, et al.
Journal of Pharmaceutical Sciences|February 24, 2025
Efflux and uptake of androgen sulfates using transporter-overexpressing HEK293 cells and membrane vesiclesArttu Uoti, Erkka Järvinen, Noora Sjöstedt, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 10, 2006
Prominent but reverse stereoselectivity in propranolol glucuronidation by human UDP-glucuronosyltransferases 1A9 and 1A10Taina Sten, Saana Qvisen, Päivi Uutela, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|April 5, 2013
A high throughput assay for the glucuronidation of 7-hydroxy-4-trifluoromethylcoumarin by recombinant human UDP-glucuronosyltransferases and liver microsomesTuomas Rahikainen, Merja R Häkkinen, Moshe Finel, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 2, 2005
Kinetic characterization of the 1A subfamily of recombinant human UDP-glucuronosyltransferasesLeena Luukkanen, Jyrki Taskinen, Mika Kurkela, et al.
Pageof 13